EXFY vs CRBP
Comparison between Expensify Inc - Class A (EXFY, Company) and Corbus Pharmaceuticals Holdings Inc (CRBP, Company).
EXFY is from the Technology sector, while CRBP is from the Healthcare sector.
5-Year PerformanceCRBP has outperformed EXFY, delivering a return of -32.7% compared to -50.9%
EXFY vs CRBP - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
EXFY vs CRBP - Historical Returns
Returns include dividend reinvestment.
EXFY vs CRBP - Annual Returns (2014 - 2026)
Returns include dividend reinvestment.
| Year | EXFY | CRBP |
|---|---|---|
| 2026 | +7.59% | +4.96% |
| 2025 | -56.86% | -32.39% |
| 2024 | +36.73% | +86.41% |
| 2023 | -71.21% | +70.62% |
| 2022 | -78.13% | -83.40% |
| 2021 | +7.16% | -51.52% |
| 2020 | N/A | -76.85% |
| 2019 | N/A | -16.64% |
| 2018 | N/A | -26.54% |
| 2017 | N/A | -15.98% |
| 2016 | N/A | +424.84% |
| 2015 | N/A | -41.90% |
| 2014 | N/A | -0.33% |
EXFY vs CRBP Drawdown Comparison
The maximum drawdown for EXFY was -98.46%, occurring on Mar 17, 2026. This drawdown has not yet recovered.
The maximum drawdown for CRBP was -99.31%, occurring on Mar 10, 2023. This drawdown has not yet recovered.
The current EXFY drawdown is -96.79%. The current CRBP drawdown is -97.34%.
| Rank | EXFY | CRBP |
|---|---|---|
| #1 | -98.46% Nov 26, 2021 - Mar 17, 2026 | -99.31% Mar 20, 2017 - Mar 10, 2023 |
| #2 | -10.04% Nov 12, 2021 - Nov 24, 2021 | -78.79% Dec 5, 2014 - Sep 8, 2016 |
| #3 | N/A | -50.97% Oct 7, 2016 - Mar 20, 2017 |
| #4 | N/A | -34.44% Nov 13, 2014 - Dec 5, 2014 |
| #5 | N/A | -17.44% Sep 19, 2016 - Oct 5, 2016 |
| #6 | N/A | -1.80% Oct 5, 2016 - Oct 7, 2016 |
Correlation
Correlation between EXFY and CRBP is -0.09 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks